Olympus (TYO:7733) said yesterday it is partnering with accelerator MedTech Innovator.
As part of the partnership, Tokyo-based Olympus will provide financial support to MedTech Innovator, and will work with the incubator to select companies that will be part of its program.
“At MedTech Innovator, we have a proven track record of identifying the most promising medical technology and digital health startups from around the world that possess the key assets and potential to improve outcomes and deliver value to the healthcare system. We are privileged to work with Olympus to improve the lives of patients by providing innovators with the expertise and guidance they most need at a critical stage in their development,” MedTech Innovator founder and CEO Paul Grand said in a prepared release.
Olympus joins Johnson & Johnson (NYSE:JNJ), AdvaMed, Baxter (NYSE:BAX), Becton Dickinson (NYSE:BDX), Amgen (NSDQ:AMGN) and a number of other medtech players who have joined on to support the accelerator.
“We understand that innovation in medical technology is not only critical, but also plays an essential role in healthcare. Olympus is excited to partner with MedTech Innovator to identify and assist emerging companies around the world to ultimately improve clinical outcomes, reduce overall costs and enhance quality of life for patients,” Olympus medical systems group prez Todd Usen said in a prepared statement.
Last month, Olympus said it inked an exclusive deal to distribute M.I. Tech’s Hanarostent self-expanding metal stents.
